Shri Ram Murti Smarak College Of Engineering And Technology, Bareilly.
The Floating Drug Delivery System (FDDS) represent a new generation of gastro-retentive drug delivery systems, which are aimed at increasing the gastro residence time and increasing the bioavailability of drug with narrow absorption windows, low solubility, or site-specific activity of the upper gastrointestinal tract. Traditional delivery methods of oral dosages are generally characterized by high rates of gastric emptying, resulting in incomplete drug absorption and variable plasma drug levels. The way to address these shortcomings is by creating FDDS that can be kept afloat in gastric fluids to facilitate sustained and controlled drug delivery. Natural mucilage is a new material that is showing promise as a substitute of synthetic polymers in FDDS because of its biocompatibility, biodegradability, non-toxicity and cost-effectiveness. Mucilage is the by-product of vegetable products like fenugreek, okra and flax seed which have been reported to have high levels of swelling, forming gel and increasing viscosity properties and are thus very helpful in floating preparations. This review comprehensively discusses the formulation strategies of mucilage-based FDDS including effervescent and non-effervescent systems and their mechanism of action, including buoyancy, density reduction and polymer swelling. In addition, another valuable point to be mentioned is that physicochemical properties of natural mucilage, such as swelling index, viscosity, and biodegradability are also of paramount importance when their usage in drug delivery control and gastric retention is concerned. The review also highlights the applications that are present, advantages over synthetic polymers and new technologies in the field. Despite some of the limitations such as lack of uniformity of the natural sources and standardization, the mucilage-based FDDS can hold a massive potential of developing safe, effective and sustainable delivery system.
GRDDS constitute an emerging technology in oral drug delivery that seeks to improve the residence time of oral dosage forms in the stomach and augment bioavailability of drugs and their therapeutic action. They are particularly effective when the absorption time of the drug in the upper gastrointestinal tract is short, it is insoluble at alkaline pH or acts locally in the stomach.[1] One of the GRDDS technologies which has attracted a lot of interest is floating drug delivery systems (FDDS) because of their potential to stay afloat on gastric fluids, thereby increasing the gastric retention time without disrupting normal gastric emptying. FDDS work through their low density relative to gastric contents to enable them to float to the surface releasing the drug in a controlled way.[2] The necessity of floating systems can be explained by the fact that traditional oral drug forms have several shortcomings, including unpredictable emptying of the stomach, which results in low absorption of drugs and variable plasma drug levels. FDDS overcome these issues by enhancing the solubility of drugs, reducing drug waste, and producing a prolonged release of drugs in the stomach. [3]
Traditionally, synthetic polymers such as hydroxypropyl methylcellulose (HPMC) and carbopol have been widely used in FDDS formulations. Nevertheless, these types of polymers have a number of drawbacks, such as the possibility of toxicity, high price, environmental impact, and non-biodegradability. Other problems like irritation caused by polymer and regulatory limitations have also prompted the search of less toxic options. [4] Natural mucilage is a promising alternative in recent years because of its biocompatibility, biodegradability, non-toxicity, and cost-effectiveness. Mucilage is a polysaccharide that is extracted by plants (seeds, leaves, and roots) and has excellent swelling, gel-forming, and drug-releasing characteristics, thus highly applicable in floating drug delivery. [5] Moreover, natural mucilage-based systems are eco-friendly, provide patients with compliance, and enhance therapeutic performance, which has been attracting more and more research in pharmaceuticals. Such materials would serve as an efficient matrix forming agent, binders, and release retardants and help to develop effective floating drug delivery systems. [6]
2. Overview of Floating Drug Delivery Systems
2.1 Definition and Concept
Floating Drug Delivery Systems (FDDS) is a gastro-retentive system, a system that assists in increasing the gastrointestinal retention of dosage in the gastric fluids. They also have lower bulk density than gastric contents (average of 1.004 g/cm 3) and therefore are able to ascend to the surface of the stomach without being forced out of the pylorus. [7].The basic principle of FDDS lies in the possibility of attaining the controlled release and the sustained release of drugs and the dose form is located in the stomach.[8] The system is then either made to give out gas, or it swells to reduce the density to allow the system to be retained suspended and then the drug to be introduced at a regulated rate after administration. [8] After administration, the system is either made to produce gas or it swells to decrease the density so that it can be kept suspended and the drug could be delivered at a controlled rate. This is particularly applicable in drugs that have a site-specific absorption in the upper gastrointestinal tract or labile in the presence of the intestinal conditions. [9].
2.2 Advantage and Limitations
Advantages
Floating Drug Delivery Systems have a number of therapeutic and formulation benefits:
Limitations
In spite of their benefits, FDDS have some limitations as well:
2.3 Classification of Floating Drug Delivery Systems
It is generally grouped into effervescent and non-effervescent systems, depending on how they reach their goal of buoyancy.
2.3.1 Effervescent Systems
Effusive systems are based on the production of gases (typically CO 2) in the effort to create buoyancy. The gas generating agents often include Sodium Bicarbonate, citric acid or tartaric acid and are commonly found in some system.
Mechanism:
Types:
Critical aspect
Systems of the effervescent type are highly utilized as they are simple and effective to gain an immediate buoyancy [12].
2.3.2 Non-Effervescent Systems
Non-effervescent systems have no dependence on the generation of gases; they make use of swelling and geling polymers to ensure buoyancy.
Mechanism:
• Gastric fluid is absorbed by hydrophilic polymers.
• There is swelling, and a gel barrier is created.
• The system becomes lower in density and floats.
Types:
Hydrodynamically balanced systems (HBS).
• Swelling systems
Floating beads and microspheres.
• Alginate-based systems
Critical aspect:
They are especially beneficial when natural polymers like mucilage are used because they are good in swelling and forming matrices [13].
Mechanism of Floating Systems.
3.1 Buoyancy Principle
The basic principle underlying Floating Drug Delivery System (FDDS) is the law of buoyancy where the dosage form floats on gastrointestinal fluid, because it is less dense than the stomach contents. Archimedes principle states that the upward forces of buoyancy of a body immersed in a fluid is equal to the weight of the fluid that it displaces. In the case where the upward force is greater than the force of gravity on the dosage form, it floats [14].
Polymers and gas-generating agents are added to FDDS to make sure that dosage form buoyed over a period of time. This increases the gastric absorption of drugs and boosts bioavailability, particularly in drugs having narrow absorption window [15].
3.2 Density Reduction
One of the key factors to floatation is density reduction. The density of the system should be less than that of the stomach fluid (~1.004g/cm3). This is possible in various mechanisms in accordance to the type of formulation:
• Effusive systems: A carbon dioxide gas is produced through acid-base reactions (e.g., Sodium Bicarbonate and Citric acid), and traps within the polymer matrix, reducing density.
• Non-effervescent systems: Swelling polymers are used, which increase in volume but not mass due to being moistened.
This increases the density so that the dosage form can be floated and remain in the stomach during prolonged durations of time [16]. Additionally, there should be ideal density/structural integrity ratio to prevent premature sinking or breaking. [17].
3.3 Swelling and Gel Formation
Gel formation and swelling are key factors in non-effervescent floating systems. The polymers, including natural mucilage, are hydrophilic and absorb the gastric fluid and hydrate rapidly, which results in:
Such a swollen gel structure does not only help in the buoyancy but also regulates drug release by providing a diffusion barrier. Floating behavior and the rate of drug release depend on the rate of swelling and gel strength [18].
The natural mucilage is especially beneficial in this mechanism because it has a high water-binding capacity and a strong gel-forming ability, thus being suitable in sustained-release floating formulations [19].
Figure 1: Mechanism of floating drug delivery system
Figure 2: Classification of Floating Drug Delivery Systems
Figure 3: A Schematic Representation of Buoyancy Mechanism.
4. Natural Mucilage: Sources and Properties.
4.1 Definition of Mucilage
Mucilage is a designation of a group of natural, high-molecular-weight polysaccharides, obtained mostly by means of plants, that are solutions that are viscous and gel-like when wet. They are normally made up of complex carbohydrates that include arabinose, galactose, rhamnose and uronic acids, which make them very good in water binding and swelling [20].
Mucilage is a very popular polymer in the manufacturing pharmaceutical industry as a binder, thickening agent, stabilizer, and controlled-release polymer, especially in gastroretentive drug delivery systems because it is biocompatible, non-toxic and eco-friendly [21].
4.2 Sources of Natural Mucilage.
Natural mucilage is mostly obtained of vegetable origin, particularly seeds, leaves, roots, and bark. These are renewable, cheap, and are common materials that make them appealing as an alternative to synthetic excipients.
Plant-Based Sources
Fenugreek
Okra
Flaxseed
Increasingly, these mucilages produced by plants are used in floating drug delivery system due to their natural source, safety, and multifunctional characteristics [22].
4.3 Physicochemical Characteristics of Mucilage.
Mucilage physicochemical properties control its performance in floating drug delivery systems:
4.3.1 Swelling Index
Swelling index is a scale of the ability of mucilage to take in water and swell. When mucilage comes in interaction with stomach fluid it hydrates and swells to form a gel-like matrix that contributes to:
• Decrease in system density.
• Enhanced buoyancy
• Controlled drug release
The desirable swelling index is high to increase the duration of gastric retention and continuous drug delivery [23].
4.3.2 Viscosity
Viscosity is an indicator of thickness and resistance to flow of mucilage solutions. It is important in:
• Creation of a powerful gel shield.
• Drug diffusion control
• Stability of the dosage form
Higher viscosity mucilage is also more effective at release retardation and matrix integrity, and therefore is appropriate in floating formulations [24].
4.3.3 Biodegradability
Natural mucilage is biodegradable by nature, meaning that it can be decomposed by the biological process into non-toxic residues.. This property ensures:
Biodegradability is a significant advantage over synthetic polymers, particularly in the development of environmentally benign pharmaceutical preparations. [25].
Table 1: Sources of Natural Mucilage and Their Biological Origin
|
S. No. |
Source (Common Name) |
Scientific Name |
Biological Origin (Part Used) |
Major Constituents |
Key Properties |
Reference |
|
1 |
Fenugreek |
Trigonella foenum-graecum |
Seeds |
Galactomannan |
High swelling, viscosity |
[64] |
|
2 |
Okra |
Abelmoschus esculentus |
Fruits (pods) |
Acidic polysaccharides |
Film-forming, thickening |
[65] |
|
3 |
Flaxseed |
Linum usitatissimum |
Seeds |
Arabinoxylans, rhamnogalacturonan |
Gel-forming, water retention |
[66] |
|
4 |
Psyllium |
Plantago ovata |
Husk (seed coat) |
Arabinoxylans |
High swelling, laxative effect |
[65] |
|
5 |
Tamarind |
Tamarindus indica |
Seeds |
Xyloglucan |
Gel-forming, stabilizing |
[66] |
|
6 |
Hibiscus |
Hibiscus rosa-sinensis |
Leaves/Flowers |
Mucilaginous polysaccharides |
Thickening, bioadhesive |
[67] |
|
7 |
Aloe vera |
Aloe barbadensis |
Leaves (gel) |
Glucomannan |
Soothing, gel-forming |
[68] |
|
8 |
Neem |
Azadirachta indica |
Bark/Leaves |
Polysaccharides |
Binding, antimicrobial |
[69] |
|
9 |
Guar gum |
Cyamopsis tetragonoloba |
Seeds |
Galactomannan |
Thickening, stabilizing |
[70] |
|
10 |
Cassia tora |
Cassia tora |
Seeds |
Galactomannan |
Swelling, binder |
[71] |
Table 2: Physicochemical Properties of Natural Mucilage Used in FDDS
|
S. No. |
Mucilage Source |
Swelling Index |
Viscosity Behavior |
Biodegradability |
Functional Role in FDDS |
Reference |
|
1 |
Fenugreek (Trigonella foenum-graecum) |
High |
High viscosity (gel-forming) |
Biodegradable |
Matrix former, sustained release |
[72] |
|
2 |
Okra (Abelmoschus esculentus) |
Moderate–High |
Pseudoplastic |
Biodegradable |
Binder, release retardant |
[73] |
|
3 |
Flaxseed (Linum usitatissimum) |
High |
High viscosity, shear-thinning |
Biodegradable |
Gel-forming agent, controlled release |
[74] |
|
4 |
Psyllium (Plantago ovata) |
Very High |
Highly viscous |
Biodegradable |
Swelling agent, buoyancy enhancer |
[75] |
|
5 |
Tamarind (Tamarindus indica) |
Moderate |
Moderate viscosity |
Biodegradable |
Stabilizer, matrix former |
[76] |
|
6 |
Aloe vera (Aloe barbadensis) |
Moderate |
Gel-like consistency |
Biodegradable |
Release modifier, gel base |
[77] |
|
7 |
Guar gum (Cyamopsis tetragonoloba) |
High |
Very high viscosity |
Biodegradable |
Thickening agent, sustained release |
[77] |
|
8 |
Cassia tora (Cassia tora) |
Moderate–High |
Moderate viscosity |
Biodegradable |
Binder, swelling agent |
[78] |
|
9 |
Hibiscus (Hibiscus rosa-sinensis) |
Moderate |
Moderate viscosity |
Biodegradable |
Bioadhesive, thickener |
[79]
|
|
10 |
Xanthan gum (microbial origin) |
High |
Highly viscous, shear-thinning |
Biodegradable |
Stabilizer, controlled release |
[80] |
5. Extraction and Purification of Mucilage
5.1 General Extraction Process
Natural mucilage extraction of plants is a series of standardized operations aimed at extracting water soluble polysaccharides, with minimum contaminants. It is typically triggered by plant material (seeds, leaves or bark) cleaning and drying, and a reduction in size to expand surface area to be extracted. The fine material is impregnated or sprayed in distilled water, then the fine material is stirred or heated mechanically to stimulate the release of mucilage to the water medium [26].The wet extract is filtered with muslin cloth or centrifuged in order to isolate the insoluble residues, to obtain a crude mucilage solution. Organic solvents such as ethanol, acetone or isopropyl alcohol are then added to the solution to be precipitated in an approximately 1:2 or 1:3 mixture to isolate mucilage and soluble impurities. The precipitated mucilage is gathered, washed and dried in controlled conditions (40 50 C) and then milled and sieved to become a fine powder which can be taken in pharmaceutical preparations. [27].
5.2 Purification Techniques
To purify mucilage, it needs to be removed to remove potential contaminants (proteins, pigments and inorganic materials) that may affect its functionality and stability. A number of techniques are used:
Developed purification procedures, including ultrafiltration and chromatography procedures are also used to achieve highly purified mucilage to be used in special pharmaceutical purposes [29].
5.3 Effects of Factors on Yield of Mucilage.
The quality and quantity of extracted mucilage will depend on the different physicochemical and process-related parameters:
These factors are essential to optimize to achieve maximum yield, purity, and functionality of mucilage in FDDS [30].
Figure 4: Flowchart of Mucilage Extraction and Purification Process
6. Use of Natural Mucilage in FDDS.
The natural mucilage plays a very significant multipurpose role in FDDS, due to its unusual physicochemical properties of hydration capacity, gel formation and biocompatibility. These characteristics enable mucilage to be an effective polymer in controlling the properties of buoyancy and drug release.
6.1 Swelling Behaviour
One of the most effective function of natural mucilage in FDDS is swelling. When mucilage comes in interaction with stomach fluid, it absorbs water quickly and volumetric expansion occurs. This swelling causes:
The swelling phenomenon varies with the polymer structure, level of hydration and the environmental pH. Very swellable mucilage creates a moist outer layer that enables the system to stay afloat over long durations [31]. Also, swelling is involved in the establishment of a diffusion barrier that controls the release of drugs [32].
6.2 Gel Formation
The presence of hydrophilic polysaccharides makes natural mucilage have an excellent gel-forming ability. When hydrated, such polymers create a sticky and adhesive gel layer surrounding the dosage form.
This gel layer has a variety of purposes:
• Functions as a shield against erosion.
• Ensures the structural soundness of the formulation.
• Gastric penetration of the fluid.
The gel layer strength and consistency have a profound effect on floating behavior and kinetics of drug release. A firmer gel guarantees longer retention and extended release [33].
6.3 Matrix Formation
Mucilage is a matrix-forming agent in floating systems, as it creates a three-dimensional network surrounding the drug. This matrix:
The matrix system enables the drug to be uniformly distributed and gives a consistent release profile. Mats based on natural mucilage are especially beneficial, as they are biodegradable and non-toxic [34].
6.4 Drug Release Retardation
The retarded release of drugs is one of the most important functions of mucilage in FDDS, as it allows the drug to have prolonged therapeutic effect. This is achieved through:
The release of drugs through mucilage-based systems typically goes through either diffusion-controlled or anomalous transport. Polymer concentration, viscosity, and cross-linking degree can be adjusted to control the release rate [35].
Natural mucilage is particularly effective in the maintenance of drug delivery because of their high water retention and gel stability, which is suitable with once-daily formulation.
|
S. No. |
Functional Role |
Mechanism of Action |
Impact on FDDS Performance |
Example Mucilage |
Reference |
|
1 |
Swelling Agent |
Absorbs gastric fluid and expands to increase volume |
Reduces density and enhances buoyancy |
Fenugreek, Psyllium |
[81] |
|
2 |
Gel-Forming Agent |
Forms viscous gel layer upon hydration |
Maintains floatation and controls drug diffusion |
Okra, Aloe-Vera |
[82] |
|
3 |
Matrix Former |
Creates a three-dimensional polymer network |
Provides structural integrity and sustained release |
Guar gum, Tamarind |
[83] |
|
4 |
Drug Release Retardant |
Forms diffusion barrier and controls erosion |
Prolongs drug release and improves bioavailability |
Flaxseed, Cassia tora |
[84] |
|
5 |
Binder |
Enhances inter-particle adhesion during compression |
Improves tablet hardness and stability |
Hibiscus, Neem |
[85] |
|
6 |
Bio-adhesive Agent |
Interacts with gastric mucosa via hydrogen bonding |
Increases gastric residence time |
Okra, Psyllium |
[86] |
|
7 |
Stabilizer |
Maintains uniform dispersion of drug and excipients |
Prevents phase separation and improves consistency |
Guar gum, Xanthan gum |
[87] |
|
8 |
Thickening Agent |
Increases viscosity of formulation |
Enhances gel strength and controls release rate |
Aloe vera, Fenugreek |
[88] |
|
9 |
Floating Enhancer |
Entraps air and reduces system density |
Improves floating lag time and duration |
Psyllium, Guar gum |
[89] |
|
10 |
Release Modifier |
Modulates diffusion and erosion rates |
Achieves controlled and sustained drug delivery |
Tamarind, Flaxseed |
[90] |
7. Floating Drug Delivery System Strategies of Formulation.
The choice of approaches to formulate floating drug delivery systems (FDDS) can vary with the dosage form, drug properties, and desired release profile. Of these, floating tablets, beads, microspheres and gels have been extensively investigated because they are effective in improving gastric retention and controlled drug delivery.
7.1 Floating Tablets
The most widely used FDDS is floating tablets as it is simple and easy to produce. Such systems are typically ready-to-wear by direct compression or wet granulation methods involving use of hydrophilic polymers and gas generating substances.
Mechanism:
Advantages:
Natural mucilage floating tablets have improved swelling and gelation, enhancing buoyancy and control of drug release [36].
7.2 Floating Beads
Multi-particulate systems of floating beads are usually prepared by ionotropic gelation methods. Beads can be produced by dropping natural polymers (e.g., alginate, mucilage) into cross-linking solutions (e.g., calcium chloride).
Mechanism:
Advantages:
The efficacy of floating beads that have been prepared with natural mucilage in the context of better buoyancy and encapsulation is evidenced [37].
7.3 Floating Microspheres
Floating microspheres (synonymous with hollow microspheres or microballoons) are low-density, hollow, round particles formed by packaging a gas or liquid inside, and are expected to be buoyed temporarily over extended times.
Preparation Techniques:
Mechanism:
Advantages:
Microspheres made of natural mucilage offer good biocompatibility and prolonged release properties [38].
7.4 Floating Gels
Floating gels are in situ gelling systems, which change to sol-to-gel in the stomach. These systems are specifically applicable when it comes to liquid formulations.
Mechanism:
Advantages:
Gels made of natural mucilage have high gelation and viscosity and are a good choice in gastro-retentive applications [39].
Figure 5: Different Formulation Approaches of Floating Systems
Table 4: Formulation Techniques and Their Characteristics
|
S. No. |
Formulation Technique |
Method Description |
Dosage Form Produced |
Key Characteristics |
Advantages |
Limitations |
Reference |
|
1 |
Direct Compression |
Powder drug + polymer compressed directly into tablets |
Floating tablets |
Simple process, uniform mixing |
Cost-effective, scalable |
Limited for poorly compressible drugs |
[91] |
|
2 |
Wet Granulation |
Drug granulated with binder solution before compression |
Floating tablets |
Improved flow and compressibility |
Suitable for high-dose drugs |
Time-consuming, moisture sensitive |
[92] |
|
3 |
Effervescent Technique |
Incorporation of gas-generating agents (e.g., NaHCO?) |
Floating tablets/capsules |
Rapid CO? generation |
Quick buoyancy, easy design |
Stability issues due to moisture |
[93] |
|
4 |
Ionotropic Gelation |
Polymer dropped into cross-linking solution (Ca²?) |
Floating beads |
Formation of gel beads |
Mild process, good encapsulation |
Variable bead size |
[94] |
|
5 |
Solvent Evaporation |
Drug-polymer solution emulsified, solvent evaporated |
Microspheres |
Hollow/porous structure |
Controlled release, buoyant particles |
Use of organic solvents |
[95] |
|
6 |
Emulsion Solvent Diffusion |
Internal phase diffuses into external phase forming particles |
Microspheres |
Uniform particle size |
High drug entrapment |
Process complexity |
[96] |
|
7 |
Spray Drying |
Atomization of drug-polymer solution into hot air |
Microspheres/powder |
Rapid drying, fine particles |
Scalable, uniform size |
Thermal degradation risk |
[97] |
|
8 |
In situ Gelation |
Liquid formulation gels in gastric environment |
Floating gels |
Sol-to-gel transition |
Easy administration, uniform distribution |
Stability challenges |
[98] |
|
9 |
Freeze Drying (Lyophilization) |
Removal of solvent by sublimation |
Porous floating systems |
Highly porous structure |
Enhanced buoyancy |
Costly process |
[99] |
|
10 |
Melt Granulation |
Drug mixed with meltable binder |
Floating tablets/granules |
Solvent-free process |
Environment-friendly |
Limited polymer selection |
[100] |
8. Floating Drug Delivery Systems-Evaluation Parameters.
The analysis of Floating Drug Delivery systems (FDDS) is vital in determining the flow characteristics, floating behavior, and controlled drug release characteristics. These parameters are categorically divided into pre-compression and post-compression studies.
8.1 Pre-compression Parameters
Investigations Before the formulation of the tablets, pre-compression studies are conducted to determine the flow ability and compressibility of the blended powder.
8.1.1 Bulk Density
The ratio of the mass of powder to the bulk volume including the spaces between particles is known as bulk density.
Significance:
Reduced bulk density is beneficial to floating systems because it helps decrease the overall density of the dosage form [40].
8.1.2 Angle of Repose
Angle of repose is an assess of flowability the powder that is the maximum angle of a pile of powder between the upper surface of the pile and the horizontal plane.
Significance:
A value that is lower than 30 degrees in angle of repose implies good flow properties, which is a requirement to make uniform pill formulations [41].
8.2 Post-compression Parameters
The post-compression tests measure of the final dose form, particularly its floating capability and drug release properties.
8.2.1 Floating lag time (FLT)
Floating lag time is the time of occurrence of the dosage form to ascend to the top of the gastric fluid following the administration.
Significance:
FLT is based on the production of gases, the hydration of polymers, and the density of pills [42].
8.2.2 Total Floating Time (TFT)
Total Floating Time is the time that the dosage form will stay on the surface of the gastric fluid.
Significance:
The optimal FDDS must be able to stay buoyant over a minimum of 12 hours to promote a lasting therapeutic effect [43].
8.2.3 Drug Release Profile
Drug release profile are done to determine the rate and extent of drug kinetics of the floating system with time.
Methods:
Kinetic Models:
The release profile aids in identifying whether the formulation results in controlled or sustained drug delivery. The formation of gel barriers in natural mucilage-based systems tends to cause diffusion-controlled release [44].
Table 5: Evaluation Parameters for Floating Drug Delivery Systems
|
S. No. |
Parameter |
Category |
Method / Equation |
Significance |
Acceptance Criteria / Observation |
Reference |
|
1 |
Bulk Density |
Pre-compression |
Mass / Bulk volume |
Determines packing ability |
Lower density preferred for buoyancy |
[101] |
|
2 |
Tapped Density |
Pre-compression |
Mass / Tapped volume |
Indicates compressibility |
Used to calculate Carr’s index |
[102] |
|
3 |
Angle of Repose |
Pre-compression |
tan θ = h/r |
Evaluates flow properties |
< 30° = good flow |
[103] |
|
4 |
Carr’s Index |
Pre-compression |
[(Tapped – Bulk)/Tapped] ×100 |
Compressibility index |
5–15% = excellent flow |
[104] |
|
5 |
Hausner Ratio |
Pre-compression |
Tapped / Bulk density |
Flowability indicator |
< 1.25 = good flow |
[105] |
|
6 |
Floating Lag Time (FLT) |
Post-compression |
Time to float in 0.1N HCl |
Indicates buoyancy onset |
< 60 seconds desirable |
[106] |
|
7 |
Total Floating Time (TFT) |
Post-compression |
Duration of floatation |
Measures gastric retention |
> 12 hours preferred |
[107] |
|
8 |
Tablet Hardness |
Post-compression |
Monsanto / Pfizer tester |
Mechanical strength |
4–8 kg/cm² |
[108] |
|
9 |
Friability |
Post-compression |
Roche friabilator |
Tablet durability |
< 1% weight loss |
[109] |
|
10 |
Drug Release Profile |
Post-compression |
Dissolution study (USP apparatus) |
Evaluates release kinetics |
Sustained/controlled release pattern |
[110] |
9. Uses of Floating Drug Delivery Systems.
The floating drug delivery system (FDDS) has become of significant significance in pharmaceutical studies because of their capability to rise the gastric residence time as well as enchance the efficacy of the drugs. They are especially applicable with drugs that need site-specific absorption, location gastric effect, or a greater bioavailability.
9.1. Drugs with Narrow Absorption Window.
Drugs have a narrow absorption window (NAW), which implies that they are mainly absorbed in the upper section of the gastrointestinal tract like the stomach or proximal small intestine. Traditional dosage forms do not have enough residence time in this region, and thus, the drug is not absorbed completely.
FDDS can address this shortcoming by holding the dosage form in the stomach longer, and in the process ensuring that the drug can be released at its optimum absorption point. This leads to:
Such drugs are levodopa, riboflavin and furosemide. The floating systems are a major way of enhancing their bioavailability by avoiding premature passages to the lower gastrointestinal tract (Huang et al., 2022)[45].
9.2 Local Stomach Action
FDDS are most useful with drug that are meant to have local therapeutic effect in the stomach, e.g., in the treatment of gastric ulcers, gastritis and infections with Helicobacter pylori.
FDDS allow the drug to have a long-term contact with the gastric mucosa resulting in:
As an illustration, antibiotics and antacids that are a floating system exhibit a greater efficacy against gastric infections because of a longer residence time [46].
9.3 Improved Bioavailability
Another most notable use of FDDS is in increasing bioavailability, especially of drugs that exhibit:
FDDS offer a controlled release environment, which enhances the absorption and dissolution of drugs by keeping the drug in the stomach. This results in:
FDDS based on natural mucilage are particularly beneficial because of their ability to swell and form a gel that additionally improves the control of drug release and bioavailability [47].
Table 6: Applications of Mucilage-Based Floating Systems with Example Drugs
|
S. No. |
Application Area |
Example Drug |
Therapeutic Use |
Role of Mucilage in FDDS |
Outcome / Benefit |
Reference |
|
1 |
Narrow Absorption Window |
Levodopa |
Parkinson’s disease |
Sustains release in stomach |
Improved absorption |
[111] |
|
2 |
Narrow Absorption Window |
Riboflavin |
Vitamin deficiency |
Prolongs gastric retention |
Enhanced bioavailability |
[112] |
|
3 |
Local Stomach Action |
Amoxicillin |
H. pylori infection |
Maintains drug in stomach |
Increased local efficacy |
[113] |
|
4 |
Local Stomach Action |
Metronidazole |
Gastric infections |
Sustained mucosal contact |
Improved antibacterial action |
[114] |
|
5 |
Improved Bioavailability |
Famotidine |
Peptic ulcer |
Enhances solubility & retention |
Increased plasma concentration |
[115] |
|
6 |
Improved Bioavailability |
Ciprofloxacin |
Bacterial infections |
Sustained release via gel matrix |
Reduced dosing frequency |
[116] |
|
7 |
Controlled Drug Release |
Propranolol HCl |
Hypertension |
Matrix formation |
Prolonged drug release |
[117] |
|
8 |
Gastroprotective Therapy |
Sucralfate |
Gastric ulcer |
Forms protective gel barrier |
Enhanced mucosal protection |
[118] |
|
9 |
Antibiotic Delivery |
Clarithromycin |
H. pylori eradication |
Sustained gastric presence |
Improved eradication rate |
[119] |
|
10 |
Antacid Therapy |
Magnesium hydroxide |
Acid neutralization |
Prolonged gastric retention |
Sustained antacid effect |
[120] |
10. Comparative Analysis: Natural vs Synthetic Polymers in FDDS.
Polymers are key to the design of floating drug delivery systems (FDDS), which affects the ability to remain afloat, release drugs, and ensure stability of the system. Historically, HPMC, carbopol, and polyethylene oxide are synthetic polymers that were commonly utilized. Nevertheless, interest has switched towards natural mucilage because it is safe, sustainable, and multifunctional.
10.1 Advantages of Natural Mucilage
10.1.1 Biocompatibility
Natural mucilage has been shown to be very biocompatible and non-toxic, thereby suitable in pharmaceutical use. Mucilage is produced by plants and is generally well-tolerated by biological systems and does not form harmful degradation products.
Moreover, natural polymers can be considered safe, making it easier to be accepted by the regulatory authorities than synthetic excipients [48].
10.1.2 Cost-Effectiveness
Natural mucilage can be found in great abundance in renewable vegetation sources and can be harvested by relatively simple and inexpensive methods.
This renders mucilage especially appealing to large-scale industrial manufacturing and developing nations, where cost factors are of great concern [49].
10.2 The limitation Natural Mucilage are as follows:
10.2.1 Batch-to-Batch Variability
Among the key issues that are linked to natural mucilage are changes in composition and performance due to variations in:
Such variability may cause inconsistencies in:
These variations can impact reproducibility and quality control in pharmaceutical formulations[50].
10.2.2 Additional Limitations
Despite such limitations, appropriate approaches of standardization, purification, and modification have the potential to substantially increase the functionality of natural mucilage in FDDS. [51].
Table 7: Comparison Between Natural Mucilage and Synthetic Polymers
|
S. No. |
Parameter |
Natural Mucilage |
Synthetic Polymers |
Impact on FDDS |
Reference |
|
1 |
Source |
Plant-derived (seeds, leaves, bark) |
Chemically synthesized |
Natural origin improves safety |
[121] |
|
2 |
Biocompatibility |
High, non-toxic |
Moderate (depends on polymer) |
Better patient compliance |
[122] |
|
3 |
Biodegradability |
Biodegradable |
May be non-biodegradable |
Eco-friendly formulations |
[123] |
|
4 |
Cost |
Low cost, easily available |
Expensive |
Economical production |
[124] |
|
5 |
Availability |
Renewable resources |
Limited, industrial synthesis |
Sustainable supply |
[125] |
|
6 |
Batch Consistency |
Variable (depends on source) |
Highly consistent |
Affects reproducibility |
[126] |
|
7 |
Mechanical Strength |
Moderate |
High |
Influences tablet hardness |
[127] |
|
8 |
Swelling Ability |
High (excellent hydration) |
Controlled/modifiable |
Enhances buoyancy |
[128] |
|
9 |
Toxicity Risk |
Minimal |
Possible (depending on polymer) |
Safer formulations |
[129] |
|
10 |
Stability |
Less stable (sensitive to moisture, microbes) |
Highly stable |
Shelf-life considerations |
[130] |
11. Latest Developments and Studies in Floating Drug Delivery Systems.
Recently, floating drug delivery system (FDDS) has been developed to improve targeted delivery, release and responsiveness of the systems. Some of the new technologies that have significantly enhanced the functionality of mucilage-based formulations are nanotechnology, hybrid polymer systems and smart floating systems.
11.1 Nanotechnology Integration
Nanotechnology has revolutionized FDDS since it now can be developed to form nano sized carriers such as nanoparticles, nanospheres and nanocomposites. These systems offer:
• Increased surface area to dissolve drug.
• High permeability and absorption.
• Improved drug stability
Natural mucilage into nanocarriers yields biocompatibility and mucoadhesive properties that lead to improved gastric retention and targeted delivery. Nano-enabled floating can also be used to achieve dual purpose, as it can also be used to deliver drugs at a nanoscale with buoyancy [52].
In addition, floating nanocarriers have been shown to be useful in the delivery of poorly soluble drugs with improved bioavailability and requiring less frequent administration [53].
1.2 Hybrid Polymer Systems
The combinations of natural mucilage and the synthetic polymers to eliminate one or the other of the limitations with the aim of achieving a certain degree of synergies are the hybrid polymer systems.
Advantages:
• Improved mechanical strength
• Greater stability and reproducibility.
• Slow absorption and release of drugs.
To demonstrate this, optimum gel strength and sustained release work are achieved using mucilage with polymers, including HPMC or carbopol. These hybrid systems also reduce the variation of the batch of natural polymers, without compromising on its biocompatibility [54].
Hybrid preparations are particularly convenient in achieving tailored drug release characteristics and they are suitable where the therapeutic requirements are complex.
11.3 Smart Floating Systems
The new generation of FDDS is known as smart floating systems, which responds to environmental signals, e.g. pH, temperature, or ionic strength.
Characteristics:
Stimulus gelation or swelling.
• Controlled discharge of drugs based on physical parameters.
• Improved targeting efficiency
They are pH-sensitive hydrogel and thermo-responsive polymers that undergo phase transitions at the gastric environment. The systems have enhanced bioadhesion and release properties, in combination with natural mucilage [55].
A personalized medicine has a high chance of success with Smart FDDS, as they can adapt to the particular physiological conditions and provide customized therapeutic effects
.
Figure 6: Emerging Trends in Mucilage-Based Floating Drug Delivery
12. Problems and Shortcomings of Mucilage-Based Floating Drug Delivery Systems.
Despite the positive opportunities of the mucilage-based floating drug delivery system (FDDS), there are a number of issues that should be addressed to ensure that this system is uniform, stable, and can be used in the industry. The key weaknesses include stability issues, reproducibility, and scale-up issues.
12.1 Stability Issues
Natural mucilage is highly delicate to environmental conditions such as temperature, humidity and microbial contamination, which can significantly affect the physicochemical properties.
Critical aspects:
These can influence the shelf-life and performance of the formulation. Compared to synthetic polymers, mucilage-based systems are likely to require additional stabilizers or preservatives to achieve stability [56].
12.2 Reproducibility
Batches to batches variability is one of the most significant drawbacks of natural mucilage and it affects reproducibility in formulations development.
Causes of Variability:
• The difference in the plant species and the geographical origin.
• Climatic and seasonal changes.
• Purity and extraction of anomalies.
Impact:
• Swelling index and viscosity change.
• IRD release profiles.
• Lack of consistency on quality.
Such inconsistency poses a challenge in coming up with standardized formulations which is one of the major requirements towards regulatory approval [57].
12.3 Challenges
Mucilage-based FDDS is commercially produced with several technical and economic hurdles to scale-up laboratory testing to an industrial level.
Limitation :
Moreover, extensive production must feature a high process optimization and validation which can be cumbersome due to the variability nature of mucilage. These difficulties can put a strain on the cost of production and commercial viability [58].
13. Future perspective of Mucilage-based Floating Drug Delivery Systems.
The floating drug delivery systems (FDDS) based on mucilage have a future of oral drug delivery because of their biocompatibility, sustainability and versatility of action. The current study is aimed at eliminating the current limitations and increasing their use in more sophisticated pharmaceutical preparations. The main future directions are the industrial potential, combination of new drugs and regulation. 13.1 Industrial Potential
Natural mucilage has great potential to be used in large-scale industrial process because of its renewable source, low cost, and environmentally friendly quality. As the use of green pharmaceutical technologies proceed to grow, there is a growing interest in mucilage-based systems as an alternative to synthetic excipients.
Opportunities:
• Commercial gastro-retentive formulations developed.
They also include:
• Nutraceutical and herbal drug delivery systems.
Nevertheless, standardized extraction procedures, quality standards, and consistent processing methods are necessary to achieve the potential of industries. The development of polymer modification and characterization should lead to an increase in scalability and industrial acceptance [59].
13.2 Novel Drug Combinations
The research on use of multiple drugs in one floating system to create combination therapy is gaining momentum in future research.
Advantages:
Such systems are especially well suited to mucilage-based matrices, which exhibit high drug-loading capacity, and controlled release properties. Also, to further improve the delivery of poorly soluble and unstable drugs, it is possible to combine mucilage with nanocarriers or smart polymers [60].
13.3 Regulatory Aspects
The regulatory concerns are very important in successful commercialization of mucilage-based FDDS. Natural polymers are regarded as safe, but their variability and absence of standardization makes them a difficult regulatory approval.
Regulatory Challenges:
In order to overcome these pressures, regulatory authorities insist on:
The regulations of the future will be in favor of using natural polymers and will include clear guidelines and assessment criteria, which will ease their integration into the modern drug delivery systems [61].
CONCLUSION
Another emerging and novel strategy of oral drug delivery improvement though natural mucilage based floating drug delivery systems (FDDS) is in the case of drugs that exhibit long residence time in the stomach. This review has fully illuminated the formulation strategies, mechanisms, physicochemical properties and uses of mucilage in floating systems. The findings observe that natural mucilage is significant in FDDS due to its outstanding swelling ability, gel forming and matrix forming abilities, which together provide in optimizing buoyancy and regulated drug liberation. Mucilage is especially interesting as an alternative to synthetic polymers because it has numerous benefits, including biocompatibility, biodegradability, cost-effectiveness, and environmental sustainability.Though these are the benefits certain problems such as batch to batch variability, stability and scale-up problems require to be taken care of in order to gain stability and consistency in the performance and industrial feasibility. Such shortcomings are bound to be mitigated with innovations such as hybrid polymer systems, incorporation of nanotechnology and smart drug delivery techniques to enhance the efficacy of mucilage-based FDDS. Mucilage based floating systems hold a huge potential in future of personalized medicine, combination drugs and environmentally friendly pharmaceutical technologies. To get these systems out of laboratory experiments and into the marketplace, continued research focusing on standardization, compliance with regulations, and innovative formulation processes will be required. In conclusion, natural mucilage is a potential flexible and sustainable excipient that can be exploited in the future of gastro-retentive drug delivery systems.
REFERENCES
Devendra Mandal, Rahul Shrivastab, Anjani Kumar Dwivedi, Gaurav Kumar Chaurasia, Amit Kumar Sharma, Aafreen, Natural Mucilage-Based Floating Drug Delivery Systems: Formulation Strategies, Mechanisms, and Applications, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 3221-3249, https://doi.org/10.5281/zenodo.20177883
10.5281/zenodo.20177883